Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2023) patentdocs.org/2023/06/vanda…
USPTO WE Event on Addressing Global Challenges patentdocs.org/2023/06/uspto…
USPTO Program on Relationship between IP and Climate Change Innovation patentdocs.org/2023/06/uspto…
Webinar on Attracting and Winning New Clients patentdocs.org/2023/06/webin…
Can Judge Michel (and John Duffy) Convince the Supreme Court to Revisit Subject Matter Eligibility? patentdocs.org/2023/05/can-j…
U.S. Trade Representative Releases 2023 Special 301 Report patentdocs.org/2023/05/us-tr…
The Quest for an "Artificial Intelligence" Inventor patentdocs.org/2023/05/the-q…
Judge Newman and the On-Going Attempts to Remove Her from the Federal Circuit patentdocs.org/2023/05/judge…
Supreme Court Decides Amgen v. Sanofi; Status Quo Extended patentdocs.org/2023/05/supre…
Senate Once Again Tries to Address Drug Pricing patentdocs.org/2023/05/senat…
Solicitor General Files Brief Advocating Certiorari Grant in Teva Pharmaceuticals v. GlaxoSmithKline; Cour... patentdocs.org/2023/05/solic…
Amicus Briefing in Amgen v. Sanofi: The Rest of the Story - Part III patentdocs.org/2023/05/amicu…
Amicus Briefing in Amgen v. Sanofi: The Rest of the Story - Part II patentdocs.org/2023/05/amicu…
Amicus Briefing in Amgen v. Sanofi: The Rest of the Story patentdocs.org/2023/05/amicu…
Stanford Asks Supreme Court to Revisit Subject Matter Eligibility on Diagnostic Claims patentdocs.org/2023/05/stanf…
ChatGPT Throws Wrench into Europe's Attempts to Regulate AI patentdocs.org/2023/04/chatg…
Sequoia Technology LLC v. Dell Inc. (Fed. Cir. 2023) patentdocs.org/2023/04/sequo…
Conference & CLE Calendar patentdocs.org/2023/04/confe…
USPTO AI Inventorship Listening Session patentdocs.org/2023/04/uspto…
